Venous Thromboembolism and Gender-Affirming Hormone Therapy: A Reappraisal of Risks and Benefits

被引：0

作者：

Dreijerink, Koen M. A. ^{[1
,2
]}

机构：

[1] Locat VU Univ Med Ctr, Amsterdam Gastroenterol Endocrinol & Metab, Ctr Expertise Gender Dysphoria, Dept Endocrinol & Metab,Amsterdam UMC,Res Inst, Amsterdam, Netherlands

[2] Locat VU Univ Med Ctr, Amsterdam Gastroenterol Endocrinol & Metab, Ctr Expertise Gender Dysphoria, Dept Endocrinol & Metab,Amsterdam UMC,Res Inst, Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands

来源：

ENDOCRINE PRACTICE | 2023年 / 29卷 / 04期

关键词：

gender-affirming hormone therapy; venous thromboembolism; TRANSGENDER; MORTALITY; MORBIDITY;

D O I：

10.1016/j.eprac.2022.12.010

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：301 / 302

页数：2

共 9 条

[1] Assessing and Addressing the Risk of Venous Thromboembolism Across the Spectrum of Gender Affirming Care: A Review [J].

Arrington-Sanders, Renata ;

Connell, Nathan T. ;

Coon, Devin ;

Dowshen, Nadia ;

Goldman, Anna L. ;

Goldstein, Zil ;

Grimstad, Frances ;

Javier, Noelle Marie ;

Kim, Ellie ;

Murphy, Martina ;

Poteat, Tonia ;

Radix, Asa ;

Schwartz, Aviva ;

St Amand, Colt ;

Streed Jr, Carl G. ;

Tangpricha, Vin ;

Toribio, Mabel ;

Goldstein, Robert H. .

ENDOCRINE PRACTICE, 2023, 29 (04) :272-278

[2] MORTALITY AND MORBIDITY IN TRANSSEXUAL PATIENTS WITH CROSS-GENDER HORMONE-TREATMENT [J].

ASSCHEMAN, H ;

GOOREN, LJG ;

EKLUND, PLE .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1989, 38 (09) :869-873

[3]

Badreddine J, 2022, EUR REV MED PHARMACO, V26, P2511, DOI 10.26355/eurrev_202204_28488

[4]

Cocchetti C, 2022, J CLIN MED, V11, P1

[5] Standards of Care for the Health of Transgender and Gender Diverse People, Version 8 [J].

Coleman, E. ;

Radix, A. E. ;

Bouman, W. P. ;

Brown, G. R. ;

de Vries, A. L. C. ;

Deutsch, M. B. ;

Ettner, R. ;

Fraser, L. ;

Goodman, M. ;

Green, J. ;

Hancock, A. B. ;

Johnson, T. W. ;

Karasic, D. H. ;

Knudson, G. A. ;

Leibowitz, S. F. ;

Meyer-Bahlburg, H. F. L. ;

Monstrey, S. J. ;

Motmans, J. ;

Nahata, L. ;

Nieder, T. O. ;

Reisner, S. L. ;

Richards, C. ;

Schechter, L. S. ;

Tangpricha, V ;

TisheInnan, A. C. ;

Van Trotsenburg, M. A. A. ;

Winter, S. ;

Ducheny, K. ;

Adams, N. J. ;

Adrian, T. M. ;

Allen, L. R. ;

Azul, D. ;

Bagga, H. ;

Basar, K. ;

Bathory, D. S. ;

Belinky, J. J. ;

Berli, J. U. ;

Bluebond-Langner, R. O. ;

Bouman, M-B ;

Bowers, M. L. ;

Brassard, P. J. ;

Byrne, J. ;

Capitan, L. ;

Cargill, C. J. ;

Carswell, J. M. ;

Chang, S. C. ;

Chelvakumar, G. ;

Corneil, T. ;

Dalke, K. B. ;

De Cuypere, G. .

INTERNATIONAL JOURNAL OF TRANSGENDER HEALTH, 2022, 23 :S1-S258

[6] Cardiovascular health in transgender people [J].

Irwig, Michael S. .

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2018, 19 (03) :243-251

[7] PULMONARY-EMBOLISM IN A TRANSSEXUAL MAN TAKING DIETHYLSTILBESTROL [J].

LEHRMAN, KL .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 235 (05) :532-532

[8] Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study [J].

Totaro, Maria ;

Palazzi, Sara ;

Castellini, Chiara ;

Parisi, Antonio ;

D'Amato, Federica ;

Tienforti, Daniele ;

Baroni, Marco Giorgio ;

Francavilla, Sandro ;

Barbonetti, Arcangelo .

FRONTIERS IN ENDOCRINOLOGY, 2021, 12

[9] Mortality and morbidity in transsexual subjects treated with cross-sex hormones [J].

vanKesteren, PJM ;

Asscheman, H ;

Megens, JAJ ;

Gooren, LJG .

CLINICAL ENDOCRINOLOGY, 1997, 47 (03) :337-342

← 1 →